Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)

Compare
7.52
+0.05
+(0.67%)
At close: 3:04:37 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
416,481.79
416,481.79
476,569.58
734,546.85
1,050,805.09
Cost of Revenue
140,431.16
140,431.16
140,939.31
171,607.54
182,124.37
Gross Profit
276,050.63
276,050.63
335,630.27
562,939.31
868,680.72
Operating Expense
251,259.15
251,259.15
376,665.68
527,775.12
767,045.13
Operating Income
24,791.48
24,791.48
-41,035.42
35,164.19
101,635.59
Net Non Operating Interest Income Expense
1,688.86
1,688.86
1,048.39
451.66
11,303.45
Pretax Income
-83,565.99
-83,565.99
122,163.03
254,615.66
439,024.10
Tax Provision
-6,691.86
-6,691.86
25,755.29
51,965.71
43,889.75
Net Income Common Stockholders
-68,853.10
-68,853.10
102,917.84
204,734.95
402,270.48
Basic EPS
-0.14
--
0.21
0.43
0.84
Diluted EPS
-0.14
--
0.21
0.43
0.84
Basic Average Shares
491,807.83
--
490,084.94
476,127.80
478,893.43
Diluted Average Shares
491,807.83
--
490,084.94
476,127.80
478,893.43
Total Operating Income as Reported
-82,973.87
-82,973.87
121,736.18
254,636.15
438,999.07
Rent Expense Supplemental
--
--
--
27.80
1,042.80
Total Expenses
391,690.31
391,690.31
517,605
699,382.66
949,169.50
Net Income from Continuing & Discontinued Operation
-68,853.10
-68,853.10
102,917.84
204,734.95
402,270.48
Normalized Income
-15,650.88
-15,650.88
22,488.40
99,427.23
228,315.89
Interest Income
1,705.62
1,705.62
1,103.65
485.66
11,558.64
Net Interest Income
1,688.86
1,688.86
1,048.39
451.66
11,303.45
EBIT
24,791.48
24,791.48
-41,035.42
35,164.19
439,024.10
EBITDA
72,043.67
72,043.67
7,703.04
82,762.58
494,705.70
Reconciled Cost of Revenue
140,431.16
140,431.16
140,939.31
171,607.54
182,124.37
Reconciled Depreciation
47,252.19
47,252.19
48,738.45
47,598.39
55,681.60
Net Income from Continuing Operation Net Minority Interest
-68,853.10
-68,853.10
102,917.84
204,734.95
402,270.48
Total Unusual Items Excluding Goodwill
-57,833.44
-57,833.44
101,916.13
132,311.88
193,276.69
Total Unusual Items
-57,833.44
-57,833.44
101,916.13
132,311.88
193,276.69
Normalized EBITDA
129,877.11
129,877.11
-94,213.09
-49,549.30
301,429.01
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4,631.23
-4,631.23
21,486.69
27,004.15
19,322.09
12/31/2021 - 6/26/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers